Tropicamide


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult : Ophth Production of mydriasis As 0.5% soln: Instill 1-2 drops 15-20 mins before examination. Production of cycloplegia As 1% soln: Instill 1-2 drops, repeated after 5 mins. May instill another drop after 20-30 mins for prolonged effect.
Dosage Details
Ophthalmic
Production of cycloplegia
Adult: Instill 1-2 drops of a 1% solution repeated after 5 minutes. An additional drop may be admin after 20-30 minutes for prolonged effect.

Ophthalmic
Production of mydriasis
Adult: Instill 1-2 drops of a 0.5% solution 15-20 minutes before examination.
Contraindications
Hypersensitivity. Narrow-angle glaucoma or shallow anterior chamber.
Special Precautions
Elderly, children, pregnancy. Hypertension, hyperthyroidism, DM, cardiac disorders. To reduce systemic absorption, press on the lacrimal sac for 1-2 minutes following instillation. Do not drive or engage in hazardous activities and protect eyes from bright illumination when pupils are dilated. May fail to produce adequate cycloplegia in children.
Adverse Reactions
Increased intraocular pressure, transient stinging, dry mouth, blurred vision, photophobia, tachycardia, headache, superficial punctate keratitis, systemic anticholinergic effects, severe CNS disturbances in children (rare).
Drug Interactions
May antagonise effects of ophthalmic carbachol, pilocarpine, or cholinesterase inhibitors.
Action
Description: Tropicamide is a tertiary amine antimuscarinic which causes relaxation of the sphincter muscle of the iris resulting in pupillary dilatation. It also causes paralysis of the ciliary muscle leading to loss of accommodation.
Onset: Mydriasis: 20-40 min; cycloplegia: 30 min.
Duration: Mydriasis: 6 hrs; cycloplegia: 6 hrs.
Storage
Store between 15-30°C. Do not refrigerate.
MIMS Class
Disclaimer: This information is independently developed by MIMS based on Tropicamide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
  • Minims Tropicamide
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in